Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review.

Published in: European journal of medical research (2022)

Anti-CGRP or anti-CGRP receptor monoclonal antibodies are a promising preventive migraine therapy which can be particularly useful for resistant chronic migraine patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
drug induced